Substituted heterocyclic thiourea compounds as a new class of anti-allergic agents inhibiting IgE/FcεRI receptor mediated mast cell leukotriene release
- 24 January 2003
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 11 (6) , 1095-1105
- https://doi.org/10.1016/s0968-0896(02)00531-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Role of a JAK3-dependent Biochemical Signaling Pathway in Platelet Activation and AggregationJournal of Biological Chemistry, 2001
- Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptaseBioorganic & Medicinal Chemistry, 1998
- Large scale isolation of intact rat basophilic leukemia (RBL-2H3) cellsJournal of Immunological Methods, 1997
- The importance of leukotrienes in airway inflammation in a mouse model of asthma.The Journal of Experimental Medicine, 1996
- Leukotriene E4 and granulocytic infiltration into asthmatic airwaysThe Lancet, 1993
- Neutrophil Recruitment by Tumor Necrosis Factor from Mast Cells in Immune Complex PeritonitisScience, 1992
- Stimulation of leukotriene production and membrane translocation of 5-lipoxygenase by cross-linking of the IgE receptors in RBL-2H3 cellsBiochemistry, 1992
- The Pathobiology of Bronchial AsthmaPublished by Elsevier ,1992
- Mast cell biologyJournal of Allergy and Clinical Immunology, 1990
- Enzymatic assembly of slow reacting substanceNature, 1980